Clinical Trials for HRYZ Biotech

Explore 4 clinical trials worldwide

Showing 1-4 of 4 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: HRYZ Biotech

Clinical Trials (4)

NCT06515314
HRYZ-T102 TCR-T Cell for AFP Positive Advanced HCC and Other Solid Tumors
PHASE1Recruiting
12 participants
Started: Aug 10, 2024 · Completed: Aug 10, 2027
1 condition1 sponsor1 location
NCT06277154
MASCT-I Combined With Doxorubicin and Ifosfamide for First-line Treatment of Advanced Soft Tissue Sarcoma
PHASE2Recruiting
148 participants
Started: Feb 21, 2024 · Completed: Feb 28, 2027
11 conditions2 sponsors1 location
NCT05952947
HRYZ-T101 Injection for HPV18 Positive Solid Tumor
PHASE1Recruiting
32 participants
Started: Nov 1, 2023 · Completed: Feb 29, 2028
6 conditions1 sponsor1 location
NCT04074564
MASCT-I Combined With Apatinib and/or Camrelizumab in the Treatment of Bone and Soft Tissue Sarcoma
EARLY_PHASE1Recruiting
60 participants
Started: Nov 22, 2019 · Completed: Dec 5, 2024
1 condition1 sponsor1 location